Skip to main content

Bureau of Laboratory Broadcast Communications

Broadcast communications are sent via e-mail by the Division of Infectious Diseases to all level A laboratories with microbiology departments in order to update the practice of clinical microbiology in Michigan laboratories. They are in PDF format and require an Acrobat Reader to view.

H3N2v Influenza

Zika Virus

Laboratory Response Network Regional Laboratory Reorganization Update

Enterovirus D68 (EV-D68)

Ebola Virus

Metallo-Beta-Lactamase (VIM) Testing

As published in the March 2014 NHSN newsletter, CDC has become aware of two Pseudomonas aeruginosa isolates which tested resistant to carbapenams but susceptble to aztreonam.
Full announcement. added 4/24/2014

MERS-CoV Updates

Possible Listeria Contamination of Blood Agar Plates

During the past week, CDC was notified of appartent isolations of Listeria from unusual specimen sources and un-inoculate media. Update #1- added 5/16/2014

New Virology Section Manager

The Bureau of Laboratories is pleased to announce the appointment of Janice Matthews-Greer, Ph.D., D(ABMM), as the Virology Section Manager in the Bureau of Laboratories. Dr. Matthews- Greer comes to MDCH from the Louisiana State University Health Science Center at Shreveport where she served as the Director of Diagnostic Virology for 10 years and held appointments as Professor of Research in Pediatrics and Professor of Clinical Pathology. She is certified as a Diplomat of the American Board of Medical Microbiology with a specialty in Medical Virology and Public Health and is active in the American Society for Microbiology (ASM) serving as a Council Representative At Large, on the ASM Professional Affairs Committee, and as an ASM Branch Lectureship Speaker. Dr. Matthews-Greer is also an accomplished researcher with over 36 articles in peer-reviewed journals and 77 abstracts presented at local, national and international meetings. Please feel free to contact her regarding any issues related to Virology and laboratory testing. She can be reached at 517-335-8099.

added 4/28/2014

Hepatitis C - Important Changes

The testing algorithm for Hepatitis C virus (HCV) will be changing as of November 1, 2013.

HCV testing will now consist of two tests, a serologic screening test and a molecular test.

The serologic screening test detects the presence of antibody to HCV, but does not differentiate between past infection, current infection, or possible false-positive results. Specimens with demonstrable antibody to HCV will automatically be tested by the molecular test for Hepatitis C viral RNA. The presence of Hepatitis C viral RNA confirms current HCV infection.

It is critical for the molecular test that specimens are kept cold (or frozen) until testing is performed. Specimens must be transported at 2 to 8 ºC or colder. Any specimen that is not cold when received at the MDCH laboratory will be screened for antibody to HCV, but antibody-positive specimens will be reported as unsatisfactory for molecular testing.

See the full announcement.

added 10/17/2013

Vibrio Request For Isolates

A recent cluster of Vibrio parahaemolyticus cases has prompted CDC to request Vibrio isolates be sent to state public health laboratories

Recall Notices

Recent Bureau of Laboratories Posters

MDCH Bureau of Laboratories Confirmatory Testing for Carbapenem-Resistant Enterobacteriaceae (CRE)

Multistate Outbreak of Fungal Meningitis Cases Resulting From Potentially Contaminated Steroid Injections

Annual Reports

Michigan CAP LPX Survey Analysis

MDCH Test Request Form

Influenza Testing

See the MDHHS Laboratory Influenza Page  for a complete list of documents available for influenza testing and surveillance.

Influenza Surveillance Report

Broadcast Communications

August 2013

June 2013

March 2013

February 2013

January 2013

October 2012

August 2012